Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | HEPTADECANOIC ACID (M-H)- | 2025 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | HEPTADECANOIC ACID (M-H)- | 4603 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | HEPTADECANOIC ACID (M-H)- | 5063 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | HEPTADECANOIC ACID (M-H)- | 5541 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | HEPTADECANOIC ACID (M-H)- | 5665 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | HEPTADECANOIC ACID (M-H)- | 5885 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | HEPTADECANOIC ACID (M-H)- | 5927 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | HEPTADECANOIC ACID (M-H)- | 6029 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | HEPTADECANOIC ACID (M-H)- | 6334 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | HEPTADECANOIC ACID (M-H)- | 6798 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | HEPTADECANOIC ACID (M-H)- | 7162 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | HEPTADECANOIC ACID (M-H)- | 7534 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | HEPTADECANOIC ACID (M-H)- | 7695 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | HEPTADECANOIC ACID (M-H)- | 8031 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | HEPTADECANOIC ACID (M-H)- | 8245 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | HEPTADECANOIC ACID (M-H)- | 8557 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | HEPTADECANOIC ACID (M-H)- | 8565 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | HEPTADECANOIC ACID (M-H)- | 8615 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | HEPTADECANOIC ACID (M-H)- | 8889 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | HEPTADECANOIC ACID (M-H)- | 8939 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | HEPTADECANOIC ACID (M-H)- | 9468 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | HEPTADECANOIC ACID (M-H)- | 9997 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | HEPTADECANOIC ACID (M-H)- | 11104 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | HEPTADECANOIC ACID (M-H)- | 11406 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | HEPTADECANOIC ACID (M-H)- | 12722 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | HEPTADECANOIC ACID (M-H)- | 17386 | Peak area normalized | female | Diabetic | no neuropathy |